Chapter 7: Idiopathic membranous nephropathy [PDF]
openaire +2 more sources
Efficacy and safety of a B-cell-driven rituximab regimen for the treatment of refractory idiopathic membranous nephropathy. [PDF]
Guo K, Zhu H, Xu X, Huang L, Li H, Li X.
europepmc +1 more source
Benzo[b]fluoranthene is involved in idiopathic membranous nephropathy by inducing podocyte injury. [PDF]
Yin L +7 more
europepmc +1 more source
Renal arteriolosclerosis impact on clinicopathological features and outcomes of idiopathic membranous nephropathy: a retrospective cohort analysis. [PDF]
Jiang R +6 more
europepmc +1 more source
Hemoglobin-associated <i>CALR</i> in proximal tubule cells can be used as a biomarker for idiopathic membranous nephropathy. [PDF]
Pang S +13 more
europepmc +1 more source
re Steroids in the Treatment of Idiopathic Membranous Nephropathy [PDF]
openaire +2 more sources
Erratum: Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy [Corrigendum]. [PDF]
europepmc +1 more source
Clinical evaluation of strengthening spleen and draining dampness in the treatment of idiopathic membranous nephropathy: a retrospective 10-year follow-up study. [PDF]
Tianxingjian KE +8 more
europepmc +1 more source
Study on the diagnostic criteria of syndrome of dampness obstruction in idiopathic membranous nephropathy based on expert consensus. [PDF]
Dan W +7 more
europepmc +1 more source
Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm. [PDF]
Huang J +6 more
europepmc +1 more source

